The present invention relates to industrially feasible and safe process for preparing 2",4"-di-O-benzoyl-1 l-N-(4-Azidobutyl)-6-0-methy(erythromycin and its impurity.
The present invention relates to advantageous process for the~~pTeparauon of 10,1 l-Dihydro-10-oxo5H-dibenz[b,f]azepine-5-carboxamide and its intermediate.
The present invention relates to an improved, robust and industrially feasible process for preparing 5-Aminolevulinic acid hydrochloride and its novel intermediates.
The present invention relates to an improved process for preparing ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzainido)propanoate of Formula
3. It is a key intermediate to prepare Dabigatran of Formula-1 and Dabigatran etexilate of Formula-2. The present invention relates to safe, economical, robust and ind...
The present invention relates to improved, safe and industrially applicable enantioseleclive enzymatic process for preparing (S)-Ethyl-3-cyano-5-methylhexanoate
The present invention relates to an improved purification process for l-(3-(trif!uoromethyI)-5>6-dihydro-[l)254]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyI)butane-l,3-dione of formula-2. Moreover, the present invention provides robust, industrially applicable process for preparing l-(3-(trifluoromethyl...
The present invention relates to an advantageous, commercially viable, industrially feasible process for preparing 7-[(3R)-3-amino-l-oxo-4-(2)4)5-trifluorophenyl) butyl]-5,6,758-tetrahydro-3- (trifluoromethy^-l^^-triazolo^S-a] pyrazine phosphate monohydrate of formula-2 and its purification.
The present invention relates to an advantageous, industrially feasible process for preparing (S)-3-(4-(2-chloro-5-iodobenzyl)phenoxy) tetrahydrofuran.
The present invention relates to improved, advantageous, safe, robust process for preparing 1-[[2'-(2,5-dihydro-5-oxo-l,2,4-oxadiazol-3-yl)[l,r-biphenyl]-4-yl]methyl]-2-ethoxy-lH-benzimidazole-7-carboxylic acid of formula-1 comprises;
The present invention relates to process for the preparation of sodium [(2S,5R)-2-carbamoyl-7-oxo-l,6-diazabicyclo[3.2.1]octan-6-yl] sulfate of formula-1
The present invention relates to process for preparing non-pharmacopoeial impurities 3-carbamoyl-5-methylhexanoic acid of formula-2 and 2-(2-amino-2-oxoethyl)-4-methylpentanoic acid of formula-3